DE60112790D1 - Amidderivate - Google Patents

Amidderivate

Info

Publication number
DE60112790D1
DE60112790D1 DE60112790T DE60112790T DE60112790D1 DE 60112790 D1 DE60112790 D1 DE 60112790D1 DE 60112790 T DE60112790 T DE 60112790T DE 60112790 T DE60112790 T DE 60112790T DE 60112790 D1 DE60112790 D1 DE 60112790D1
Authority
DE
Germany
Prior art keywords
accompanied
amide derivative
infection
herpes
hsv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60112790T
Other languages
English (en)
Other versions
DE60112790T2 (de
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Yoji Miyazaki
Hiroshi Suzuki
Eiichi Nakai
Shunji Kageyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rational Drug Design Laboratories Tokio/tokyo Jp
Astellas Pharma Inc
Original Assignee
RATIONAL DRUG DESIGN LABORATORIES TOKIO/TOKYO
RATIONAL DRUG DESIGN LAB TOKIO
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RATIONAL DRUG DESIGN LABORATORIES TOKIO/TOKYO, RATIONAL DRUG DESIGN LAB TOKIO, Yamanouchi Pharmaceutical Co Ltd filed Critical RATIONAL DRUG DESIGN LABORATORIES TOKIO/TOKYO
Publication of DE60112790D1 publication Critical patent/DE60112790D1/de
Application granted granted Critical
Publication of DE60112790T2 publication Critical patent/DE60112790T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70Sulfur atoms
    • C07D277/74Sulfur atoms substituted by carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60112790T 2000-11-10 2001-11-08 Amidderivate Expired - Lifetime DE60112790T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000344354 2000-11-10
JP2000344354 2000-11-10
PCT/JP2001/009790 WO2002038554A1 (fr) 2000-11-10 2001-11-08 Derives amides

Publications (2)

Publication Number Publication Date
DE60112790D1 true DE60112790D1 (de) 2005-09-22
DE60112790T2 DE60112790T2 (de) 2006-05-18

Family

ID=18818562

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112790T Expired - Lifetime DE60112790T2 (de) 2000-11-10 2001-11-08 Amidderivate

Country Status (11)

Country Link
US (1) US6949543B2 (de)
EP (1) EP1340750B8 (de)
JP (1) JP3913172B2 (de)
KR (1) KR20030045180A (de)
CN (1) CN1473157A (de)
AT (1) ATE302197T1 (de)
AU (1) AU2002212734A1 (de)
CA (1) CA2428184C (de)
DE (1) DE60112790T2 (de)
ES (1) ES2247177T3 (de)
WO (1) WO2002038554A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003235889A1 (en) * 2002-05-09 2003-11-11 Rational Drug Design Laboratories Amide derivatives
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
WO2005020921A2 (en) 2003-08-29 2005-03-10 Exelixis, Inc. C-kit modulators and methods of use
JP2007523087A (ja) * 2004-02-11 2007-08-16 アイアールエム・リミテッド・ライアビリティ・カンパニー Lxrモジュレーターとしての化合物および組成物
EP1748997A1 (de) * 2004-05-13 2007-02-07 Boehringer Ingelheim International Gmbh Substituierte thiophen-2-carbonsäureamide, deren herstellung und deren verwendung als arzneimittel
JP4832093B2 (ja) * 2005-02-02 2011-12-07 アステラス製薬株式会社 テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体の製造方法
DE602006016069D1 (de) * 2005-02-02 2010-09-23 Astellas Pharma Inc Therapeutischer wirkstoff zur behandlung von herpes progenitalis nach der entwicklung von läsionen
JPWO2006082822A1 (ja) * 2005-02-02 2008-06-26 アステラス製薬株式会社 アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤
EP1857108B1 (de) * 2005-02-02 2010-12-08 Astellas Pharma Inc. Vorbeuge- oder heilmittel für krankheiten in zusammenhang mit dem herpes-virus
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体を含有する医薬組成物
BRPI0715729A2 (pt) * 2006-08-30 2013-09-24 Hoffmann La Roche inibidores para glyt-1
WO2009105774A2 (en) * 2008-02-21 2009-08-27 Sequoia Pharmaceuticals, Inc. Amino acid inhibitors of cytochrome p450
EP2351565A1 (de) 2008-10-20 2011-08-03 Astellas Pharma Inc. Medizin zur verhinderung oder behandlung von schmerzen aufgrund von gürtelrose
EP2616073A4 (de) * 2010-09-13 2015-02-18 Microbiotix Inc Hemmer des eindringens von viren in säugetier-wirtszellen
WO2012073375A1 (ja) 2010-12-03 2012-06-07 富士通株式会社 新規化合物、並びに、キネシンスピンドルタンパク質阻害剤及びその応用
CN103275034B (zh) * 2013-04-16 2015-07-08 南京工业大学 一类小分子cathepsin D抑制剂的制备方法
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0871619T3 (da) * 1995-12-29 2003-03-03 Boehringer Ingelheim Pharma Phenylthiazolderivater med antiherpesvirusegenskaber
WO1999042455A1 (en) * 1998-02-19 1999-08-26 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds

Also Published As

Publication number Publication date
US20040034232A1 (en) 2004-02-19
CA2428184C (en) 2010-03-30
ES2247177T3 (es) 2006-03-01
EP1340750A1 (de) 2003-09-03
AU2002212734A1 (en) 2002-05-21
ATE302197T1 (de) 2005-09-15
EP1340750B1 (de) 2005-08-17
JP3913172B2 (ja) 2007-05-09
CA2428184A1 (en) 2002-05-16
WO2002038554A1 (fr) 2002-05-16
DE60112790T2 (de) 2006-05-18
KR20030045180A (ko) 2003-06-09
EP1340750B8 (de) 2005-10-19
EP1340750A4 (de) 2004-01-21
JPWO2002038554A1 (ja) 2004-03-18
CN1473157A (zh) 2004-02-04
US6949543B2 (en) 2005-09-27

Similar Documents

Publication Publication Date Title
DE60112790D1 (de) Amidderivate
CY1115461T1 (el) Παραγωγα αμιδιων
ES2160046A1 (es) Derivados pentapeptidicos.
EA201270632A1 (ru) 2'-фтор-6'-метилен карбоциклические нуклеозиды и способы лечения вирусных инфекций
ATE229945T1 (de) Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
BRPI0411900A (pt) compostos antivirais e métodos
BR0308492A (pt) Compostos cefem possuindo amplo espectro antibacteriano
ATE512973T1 (de) Nukleosid-arylphosphoramidate und ihre verwendung als antivirale mittel zur behandlung von hepatitis-c-virus
CY1108036T1 (el) Κυτταρικη συσσωρευση φωσφονικων αναλογων ενωσεων αναστολεα πρωτεασης του ιου ανοσολογικης ανεπαρκειας του ανθρωπου (hiv) και οι ενωσεις ως τετοιες
CY1108578T1 (el) Φαρμακευτικες συνθεσεις (κιτ) περιλαμβανοντας ενωσεις διϋδροπυριδινονης και εναν ανοσορυθμιστικο (ή εναν αντιφλεγμονωδη) παραγοντα και οι χρησεις αυτων
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
DE69624813D1 (de) Robustaflavon und dessen derivate als antivirales mittel
MA55020A (fr) Dérivés d'amide utiles dans le traitement d'une infection par le virus de l'hépatite b ou de maladies induites par le virus de l'hépatite b
HUP0302664A2 (hu) Vakcináció gazdasejttel asszociált herpeszvírusok ellen
NO20012834D0 (no) Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus
BR0215067A (pt) Piridoquinoxalinas antivirais
DE59704973D1 (de) Nucleosid-derivate mit photolabilen schutzgruppen
NO20012838L (no) Tiourea-inhibitorer for herpesvirus
TR200101664T2 (tr) Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri
ATE506367T1 (de) Antivirale pyrimidinnukleosidderivate
ATE124050T1 (de) Chirale 2-(phosphonomethoxy)propyl-guanine als antivirale agentien.
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
DE69731483D1 (de) Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen
EP1844776A4 (de) Wirkstoff zur prävention/behandlung von erkrankungen infolge von acyclovir-resistentem herpesvirus

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: RATIONAL DRUG DESIGN LABORATORIES, TOKIO/TOKYO, JP

Owner name: ASTELLAS PHARMA, INC., TOKIO/TOKYO, JP

8364 No opposition during term of opposition